Completed
A key objective of medicines regulatory authorities is to protect public health by ensuring the quality, safety and efficacy of medicines. Medicines regulatory authorities use mutual recognition/reliance agreements and informal practices of recognition/reliance in various range and approaches. At the request of the U.S. Food and Drug Administration's Office of International Programs, the National Academies have convened a committee to analyze and assess how the regulatory authorities of different countries use such regulatory practices and will evaluate their effects on public health, use of resources, and essential regulatory competencies.
Events
Discover
Events
Right Now & Next Up
Stay in the loop with can’t-miss sessions, live events, and activities happening over the next two days.
NAS Building Guided Tours Available!
Participate in a one-hour guided tour of the historic National Academy of Sciences building, highlighting its distinctive architecture, renowned artwork, and the intersection of art, science, and culture.